Atopic Dermatitis Digital Highlights - Podcasts
Faculty Interview Podcasts

Faculty Interview Podcasts

Evolving Paradigms in Atopic Dermatitis

Evolving Paradigms in Atopic Dermatitis

Fernanda Schmidt, MD shares some clinical pearls about the evolving paradigms in AD, including:

  • What are the inside-out and outside-in mechanisms of AD?
  • Is there a difference between these mechanisms across the age spectrum – from children to adults?
  • Can we halt the atopic march by repairing the skin, or is it more than “skin deep”?

Podcast also available on:

Perspectives on emerging AD therapies

Perspectives on emerging AD therapies

Leon Kircik, MD discusses the potential role of emerging AD treatments, including:

  • Why has atopic dermatitis lagged behind compared to psoriasis in terms of approved targeted treatments?
  • What are some of the most promising therapies that will likely be part of the AD treatment table in the near future?
  • Do you foresee that they will be also approved for pediatric AD, or only for the adult population?
  • In terms of assessing disease severity, how practical are the scales used in clinical trials? Should we put more emphasis on patient-reported outcomes?

Podcast also available on:

Pearls on integrating newer AD treatments

Pearls on integrating newer AD treatments

Lawrence Schachner, MD discusses clinical pearls on the diagnosis and treatment of pediatric AD, including:

  • How do we make sure that we correctly diagnose atopic dermatitis? What are some clinical pearls you can share for our audience?
  • Since now dupilumab is approved for children with atopic dermatitis, what is its role and where would it fit into the “Schachner ladder”?
  • How do crisaborole and dupilumab fit into the long-term care of AD? For how long should they be used?

Podcast also available on:

The promise of JAK inhibitors in AD

The promise of JAK inhibitors in AD

Neal Bhatia, MD discusses the potential role of JAKis in AD, including:

  • What changes would JAKis bring to the treatment of AD in the near future?
  • What are some JAKis currently under clinical development for AD?
  • Do you foresee that JAKis will play a role in both adult and pediatric AD?
  • Where do you think they will fit in with the other recently-approved treatments for AD, or overall in the treatment regimen?
  • What are the long-term implications for dermatology practice?

Podcast also available on:

Sign up to be notified about upcoming events, new offerings and promotions

Join Our Mailing List

Call us to discuss which services would best fit your needs

561-893-8625